Valve replacement in children less than 5 years of age

Between 1966 and 1984, there were 63 children less than 5 years of age who underwent 70 valve replacements (49 mitral [5 repeat], 6 aortic, 11 tricuspid [systemic ventricle; 2 repeat]), 2 tricuspid [pulmonary ventricle] and 1 multiple [mitral-aortic]) at Children's Hospital. Tissue valves were used in 20%. Since 1980, only Bjork-Shiley and St. Jude valves have been used. The most common indication for valve replacement was mitral regurgitation after repair of atrioventricular (AV) canal (34%). Mortality dropped considerably over time: 76% before 1979, 33% from 1979 to 1982 and 22% since 1982. More than two-thirds of fatalities were operative deaths, usually within 3 days of surgery. Actuarial survival curves for those operated on since 1980 predict 1 and 5 year survival of 73 and 51%, respectively. For the 46 operative survivors 1 and 5 year valve survival was 97 and 70%, respectively. Postoperative hemodynamics were significantly improved on elective postoperative catheterizations. All but one patient with non-tissue valves received anticoagulant therapy. Postoperative complications included thromboembolism (1.6/100 patients-years) and hemorrhage (0.8/100 patient-years). The frequency of intravascular hemolysis and endocarditis was 1.6%, comparable with adult experience. Complete heart block requiring a pacemaker developed in nine patients (14.1%), in all after AV valve replacement. Valve replacement in young children generally results in considerable hemodynamic improvement. The mortality rate remains above that observed in adults but has declined considerably for those operated on after 1980.

This article has been cited by other articles:

				P. Monagle, E. Chalmers, A. Chan, G. deVeber, F. Kirkham, P. Massicotte, and A. D. Michelson Antithrombotic Therapy in Neonates and Children: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition) Chest, June 1, 2008; 133(6_suppl): 887S - 968S. [Abstract] [Full Text] [PDF]

				H. L. Bartlett, D. L. Atkins, T. L. Burns, K. J. Engelkes, S. J. Powell, C. B. Hills, and J. H. Moller Early Outcomes of Tricuspid Valve Replacement in Young Children Circulation, January 23, 2007; 115(3): 319 - 325. [Abstract] [Full Text] [PDF]

				H. A. Vohra, S. Laker, O. Stumper, J. V. De Giovanni, J. G. Wright, D. J. Barron, and W. J. Brawn Predicting the performance of mitral prostheses implanted in children under 5 years of age. Eur. J. Cardiothorac. Surg., May 1, 2006; 29(5): 688 - 692. [Abstract] [Full Text] [PDF]

				P. Monagle, A. Chan, P. Massicotte, E. Chalmers, and A. D. Michelson Antithrombotic Therapy in Children*: The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy Chest, September 1, 2004; 126(3_suppl): 645S - 687S. [Abstract] [Full Text] [PDF]

				G. Raghuveer, C. A. Caldarone, C. B. Hills, D. L. Atkins, J. M. Belmont, and J. H. Moller Predictors of Prosthesis Survival, Growth, and Functional Status Following Mechanical Mitral Valve Replacement in Children Aged <5 Years, a Multi-Institutional Study Circulation, September 9, 2003; 108(90101): II-174 - 179. [Abstract] [Full Text] [PDF]

				C. A. Caldarone, G. Raghuveer, C. B. Hills, D. L. Atkins, T. L. Burns, D. M. Behrendt, and J. H. Moller Long-Term Survival After Mitral Valve Replacement in Children Aged <5 Years: A Multi-Institutional Study Circulation, September 18, 2001; 104(90001): I-143 - 147. [Abstract] [Full Text] [PDF]

				C. Alexiou, M. Galogavrou, Q. Chen, A. McDonald, A. P. Salmon, B. K. Keeton, M. P. Haw, and J. L. Monro Mitral valve replacement with mechanical prostheses in children: improved operative risk and survival Eur. J. Cardiothorac. Surg., July 1, 2001; 20(1): 105 - 113. [Abstract] [Full Text] [PDF]

				W. Streif, M. Andrew, V. Marzinotto, P. Massicotte, A.K.C. Chan, J.A. Julian, and L. Mitchell Analysis of Warfarin Therapy in Pediatric Patients: A Prospective Cohort Study of 319 Patients Blood, November 1, 1999; 94(9): 3007 - 3014. [Abstract] [Full Text] [PDF]